Article Versions Notes

Kim YS, Potashnikova DM, Gisina AM, Kholodenko IV, Kopylov AT, Tikhonova OV, Kurbatov LK, Saidova AA, Tvorogova AV, Kholodenko RV, et al. TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype. International Journal of Molecular Sciences. 2022; 23(17):9874. https://doi.org/10.3390/ijms23179874

Kim, Yan S., Daria M. Potashnikova, Alisa M. Gisina, Irina V. Kholodenko, Arthur T. Kopylov, Olga V. Tikhonova, Leonid K. Kurbatov, Aleena A. Saidova, Anna V. Tvorogova, Roman V. Kholodenko, and et al. 2022. "TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype" International Journal of Molecular Sciences 23, no. 17: 9874. https://doi.org/10.3390/ijms23179874

Kim, Y. S., Potashnikova, D. M., Gisina, A. M., Kholodenko, I. V., Kopylov, A. T., Tikhonova, O. V., Kurbatov, L. K., Saidova, A. A., Tvorogova, A. V., Kholodenko, R. V., Belousov, P. V., Vorobjev, I. A., Zgoda, V. G., Yarygin, K. N., & Lupatov, A. Y. (2022). TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype. International Journal of Molecular Sciences, 23(17), 9874. https://doi.org/10.3390/ijms23179874